SCHEMBL6606767

SCHEMBL6606767

CCCCC(NC(=O)O)C(=O)C(=O)Nc1nccs1

nearest known ligand 0.71

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CTSK P43235 4/20 0.71
HSPA5 P11021 2/20 0.56
ALDH1A1 P00352 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
PKM P14618 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
CYP2C9 P11712 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C19 P33261 1/20 0.49
CTSV O60911 1/20 0.48
CTSS P25774 1/20 0.48
HTT P42858 1/20 0.45
ADORA2A P29274 1/20 0.45
FFAR2 O15552 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6606757 1.00 CTSK (0.71) CTSKHSPA5ALDH1A1SMN1; SMN2PKM
SCHEMBL6604125 0.77 CTSK (0.71) CTSKALDH1A1SMN1; SMN2PKMCTSV
SCHEMBL6607233 0.77 CTSK (0.71) CTSKALDH1A1SMN1; SMN2PKMCTSV
SCHEMBL6619380 0.76 CTSK (0.59) CTSKHSPA5ALDH1A1SMN1; SMN2PKM
SCHEMBL6614274 0.74 CTSK (0.71) CTSKCTSVCTSS
SCHEMBL4317649 0.74 CTSK (0.71) CTSKCTSVCTSS
SCHEMBL4317659 0.74 CTSK (0.71) CTSKCTSVCTSS
SCHEMBL6361968 0.74 ALDH1A1 (0.57) HSPA5ALDH1A1PKMCYP2C9CYP1A2
SCHEMBL6361959 0.74 ALDH1A1 (0.57) HSPA5ALDH1A1PKMCYP2C9CYP1A2
SCHEMBL5637491 0.72 CTSK (0.53) CTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1411933-A1 ALPHA-KETOAMIDE DERIVATIVES AS CATHEPSIN K INHIBITORS SmithKline Beecham Corporation (US) 2004-04-28 EP disclosed
WO-2003013518-A1 ALPHA-KETOAMIDE DERIVATIVES AS CATHEPSIN K INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-02-20 WO disclosed